A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of HSY244 in Participants With Atrial Fibrillation
Clinical trial NCT04582409 · TERMINATED
Trial details
- NCT number
- NCT04582409
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2022-07-11
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.